HT006.2.2

N/A

Report date: 2026/05/28 20:00:21

Base Information

Drug NameHT006.2.2
Drug Alias NameHT006.2.2HT-006.2.2
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNerve growth factor receptor Trk-A agonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsKeratitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Hiteck Biological Pharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuhan Hiteck Biological Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsKeratitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A